| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/05/2002 | US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer |
| 12/05/2002 | US20020183273 Compositions and methods for improving kidney function |
| 12/05/2002 | US20020183271 Administering to the patient a human MDA-7 polypeptide or a nucleic acid expressing the human MDA-7 polypeptide in eukaryotic cells, whereby the MDA-7 polypeptide inhibits angiogenesis in the patient |
| 12/05/2002 | US20020183269 Novel compounds |
| 12/05/2002 | US20020183268 Coding sequences of the human BRCA1 gene |
| 12/05/2002 | US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount |
| 12/05/2002 | US20020183251 For use as vaccines, and other drugs for the diagnosis and therapy of prostate cancer |
| 12/05/2002 | US20020183250 For use in therapy of sleep disorders |
| 12/05/2002 | US20020182733 Vector and methods of use for selective expression of genes in sites of angiogenesis in vivo |
| 12/05/2002 | US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors |
| 12/05/2002 | US20020182718 Method and device for the handling of samples and reagents |
| 12/05/2002 | US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 12/05/2002 | US20020182685 In vivo generation of antibodies against antigens secreted in a host by transfected MEL cells |
| 12/05/2002 | US20020182683 Vascular endothelial growth factor 2 |
| 12/05/2002 | US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia |
| 12/05/2002 | US20020182667 Methods of modulating T lymphocyte costimulation |
| 12/05/2002 | US20020182664 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 12/05/2002 | US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect |
| 12/05/2002 | US20020182258 Microparticles for delivery of nucleic acid |
| 12/05/2002 | US20020182249 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| 12/05/2002 | US20020182229 Anaerobe targeted enzyme mediated prodrug therapy |
| 12/05/2002 | US20020182219 Cancer immunotherapy |
| 12/05/2002 | US20020182215 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 12/05/2002 | US20020182193 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of myopathies like muscular dystrophy, for improving transplantation success |
| 12/05/2002 | US20020182192 Administering bone marrow cells to the mammal, such as allogeneic cells or autologous cells engineered to express dystrophin or other gene products |
| 12/05/2002 | US20020182190 Microparticle protection of therapeutic agents |
| 12/05/2002 | US20020182189 Compositions and methods for the repair and construction of bone and other tissue |
| 12/05/2002 | US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin |
| 12/05/2002 | US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 12/05/2002 | US20020182180 Method for inducing immunity to viruses |
| 12/05/2002 | DE10127572A1 Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen Tools for diagnostics, molecular definition and therapy development of chronic inflammatory joint diseases |
| 12/05/2002 | CA2487014A1 A method of improving the growth performance of an animal |
| 12/05/2002 | CA2452707A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 12/05/2002 | CA2448985A1 Gene delivery via a baculovirus vector |
| 12/05/2002 | CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins |
| 12/05/2002 | CA2448620A1 Vaccination against the feline immunodeficiency virus |
| 12/05/2002 | CA2448567A1 Modulators of nucleic acid ligands |
| 12/05/2002 | CA2448362A1 B7 related protein-2 molecules and uses thereof |
| 12/05/2002 | CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/05/2002 | CA2448320A1 Ribozyme based treatment of female reproductive diseases |
| 12/05/2002 | CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | CA2448104A1 Wnv core protein/capsid interacting protein and uses of the same |
| 12/05/2002 | CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 12/05/2002 | CA2445611A1 P-cadherin as a target for anti-cancer therapy |
| 12/05/2002 | CA2441937A1 Chromosome-based platforms |
| 12/04/2002 | EP1262555A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 12/04/2002 | EP1262554A2 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/04/2002 | EP1262199A1 Vectors for enhanced expression of VEGF for disease treatment |
| 12/04/2002 | EP1262188A1 Improved neuronal gene transfer |
| 12/04/2002 | EP1261745A2 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261714A2 Muteins of interleukin-13 (il-13) |
| 12/04/2002 | EP1261711A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 12/04/2002 | EP1261703A1 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261694A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 12/04/2002 | EP1261645A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 12/04/2002 | EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 12/04/2002 | EP1261640A2 Inflammation-related gene |
| 12/04/2002 | EP1261639A2 Chondromodulin-i related peptide |
| 12/04/2002 | EP1261638A2 Human fgf-23 gene and gene expression products |
| 12/04/2002 | EP1261637A1 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261635A1 Human polynucleotides, polypeptides, and antibodies |
| 12/04/2002 | EP1261634A1 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261633A2 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses |
| 12/04/2002 | EP1261629A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 12/04/2002 | EP1261627A2 Antibodies against plasma cells |
| 12/04/2002 | EP1261618A2 Nucleic acids, proteins, and antibodies |
| 12/04/2002 | EP1261380A1 Nucleic acids, proteins and antibodies |
| 12/04/2002 | EP1261379A2 Genetic modification of the lung as a portal for gene delivery |
| 12/04/2002 | EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 12/04/2002 | EP1261377A2 Immunomodulatory formulations and methods for use thereof |
| 12/04/2002 | EP1261372A2 Method of treating cancer with anti-neurotrophin agents |
| 12/04/2002 | EP1261369A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 12/04/2002 | EP1261354A1 Delivery system and methods for gene therapy |
| 12/04/2002 | EP1261352A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 12/04/2002 | EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 12/04/2002 | EP1045702A4 Methods of controlling cell differentiation and growth using a fusion protein and a drug |
| 12/04/2002 | EP0938298B1 Liposome-based composition |
| 12/04/2002 | EP0836643A4 Immunoprotective barrier for transplantation of cells |
| 12/04/2002 | EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 12/04/2002 | CN1383452A Compsns. and methods for treating cells having double minute DNA |
| 12/04/2002 | CN1382492A DNA vaccine carrier |
| 12/04/2002 | CN1382448A Genetic switch medicine for treating tumor |
| 12/04/2002 | CN1382377A Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism |
| 12/04/2002 | CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy |
| 12/03/2002 | US6489495 Cationic amphiphiles for liposomal gene transfer |
| 12/03/2002 | US6489464 Branched oligonucleotides as pathogen-inhibitory agents |
| 12/03/2002 | US6489463 Thymosin β-15 promoter and uses thereof |
| 12/03/2002 | US6489460 Cloned DNA encoding mammalian occludins |
| 12/03/2002 | US6489459 Hop=homolog of presenilin; isolated nucleic acid, vector and host cell; related to alzheimer's disease |
| 12/03/2002 | US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6 |
| 12/03/2002 | US6489307 Reducing the level of transcription of beta 1-adrenoceptor polypeptide-specific mrna in a mammalian host cell, by administering oligonucleotide; reduces receptor expression; hypotensive effect |
| 12/03/2002 | US6489306 Method of intranasal gene transfer for protection against respiratory infection |
| 12/03/2002 | US6489305 Methods and compositions for the treatment of ocular diseases |
| 12/03/2002 | US6489139 FabZ from Staphylococcus aureus |
| 12/03/2002 | US6489128 Methods for detecting cancer of the central nervous system |
| 12/03/2002 | US6489104 Screening for a dna encoding a protein that regulates the human p27.sup.kip1 promoter activity of a promoter dna, said promoter dna comprising at least a substantial portion of a fragment extending from nucleotide 2795 to nucleotide 3133 of |
| 12/03/2002 | US6488925 Macrophage inflammatory protein-4 (MIP-4) polypeptides |
| 12/03/2002 | CA2213198C Gene therapy by anti-tgf-b agents |
| 12/03/2002 | CA2126103C Transfection of lung via aerosolized transgene delivery |